COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,035 Articles (21,527 medRxiv, 7,508 bioRxiv)

Most recent first Previous |  Page 1944: Articles 19431-19440  | Next

Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave
Reynolds, C. J., Swadling, L., Gibbons, J. M., Pade, C., Jensen, M., Diniz, M. O., Schmidt, N. M., Butler, D. K., Amin, O. E., Bailey, S. N. L., Talyor, S., Jones, J., Jones, M., Lee, W. Y. J., Rosenheim, J., Chandran, A., Joy, G., Di Genova, C., Temperton, N. J., Lambourne, J., Cutino-Moguel, T., Andiapen, M., Fontana, M., Smit, A., Semper, A., O'Brien, B., Chain, B., Brooks, T., Manisty, C., Treibel, T., Moon, J., COVIDsortium Investigators, , Noursadeghi, M. C., COVIDsortium Immune correlates network, , Altmann, D. M., Mani, M. K., McKnight, A., Boyton, R. J.
10.1101/2020.10.13.20211763 — Posted: 2020-10-14
Prone positioning of non-intubated patients with COVID-19 - A Systematic Review and Meta-analysis
PONNAPA REDDY, M., SUBRAMANIAM, A., LIM, Z. J., ZUBAREV, A., AFROZ, A., BILLAH, B., TIRUVOIPATI, R., RAMANATHAN, K., WONG, S. N., BRODIE, D., FAN, E., SHEKAR, K.
10.1101/2020.10.12.20211748 — Posted: 2020-10-14
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
Dugas, M., Grote-Westrick, T., Vollenberg, R., Lorentzen, E., Brix, T., Schmidt, H., Tepasse, P.-R., Kuehn, J.
10.1101/2020.10.12.20211599 — Posted: 2020-10-14 Discussion: Onsite
Systematic analysis of electronic health records identifies drugs reducing risk of COVID-19 hospitalization and severity
Israel, A., Schaffer, A., Cicurel, A., Feldhamer, I., Tal, A., Cheng, K., Sinha, S., Schiff, E., Lavie, G., Ruppin, E.
10.1101/2020.10.13.20211953 — Posted: 2020-10-14
Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality criteria for services
Ladds, E., Rushforth, A., Wieringa, S., Taylor, S., Rayner, C., Husain, L., Greenhalgh, T.
10.1101/2020.10.13.20211854 — Posted: 2020-10-14 Discussion: Onsite
Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis
Lai, L. Y. H., Golozar, A., Sena, A. G., Margulis, A. V., Haro, N., Casajust, P., Valveny, N., Prats-Uribe, A., Minty, E. P., Ahmed, W. -U.-R., Alshammari, T. M., Morales, D. R., Alghoul, H., Alser, O., Dawoud, D., Zhang, L., Posada, J. D., Shah, N., Blacketer, C., Areia, C., Subbian, V., Nyberg, F., Lane, J. C. E., Suchard, M. A., Gong, M., Recalde, M., Jonnagaddala, J., Shah, K., Roel, E., Vizcaya, D., Fortin, S., Cheng, R.-f. J., Reich, C., Hripcsak, G., Rijnbeek, P., Ryan, P. B., Kostka, K., Duarte-Salles, T., PRIETO-ALHAMBRA, D.
10.1101/2020.10.13.20211821 — Posted: 2020-10-14
From more testing to smart testing: data-guided SARS-CoV-2 testing choices
van Beek, J., Igloi, Z., Boelsums, T., Fanoy, E., Gotz, H., Molenkamp, R., van Kampen, J., Geurtsvankessel, C., van de Vijver, D., Koopmans, M.
10.1101/2020.10.13.20211524 — Posted: 2020-10-14 Discussion: Onsite
Preventing COVID-19 spread in closed facilities by regular testing of employees - an efficient intervention in long-term care facilities and prisons
Tsoungui Obama, H. C. J., Adil Mahmoud Yousif, N., Hassan Mohamed Alawam Nemer, L., Ngougoue Ngougoue, P. M., Ngwa, G. A., Teboh-Ewungkem, M., Schneider, K.
10.1101/2020.10.12.20211573 — Posted: 2020-10-14
Return to University Campuses Associated with 9% Increase in New COVID-19 Case Rate
Bagwell Adams, G., Shannon, J., Shannon, S.
10.1101/2020.10.13.20212183 — Posted: 2020-10-14 Discussion: Offsite
Validation of a Derived International Patient Severity Phenotype to Support COVID-19 Analytics from Electronic Health Record Data
Klann, J. G., Weber, G. M., Estiri, H., Moal, B., Avillach, P., Hong, C., Castro, V. M., Maulhardt, T., Tan, A. L., Geva, A., Beaulieu-Jones, B. K., Malovini, A., South, A. M., Visweswaran, S., Omenn, G. S., Ngiam, K. Y., Mandl, K. D., Boeker, M., Olson, K. L., Mowery, D. L., Morris, M., Follett, R. W., Hanauer, D. A., Bellazzi, R., Moore, J. H., Loh, N. H. W., Bell, D. S., Wagholikar, K., Chiovato, L., Tibollo, V., Rieg, S., Li, A. L., Jouhet, V., Schriver, E., Samayamuthu, M. J., Xia, Z., The Consortium for Clinical Characterization of COVID-19 by EHR (4CE), , Kohane, I. S., Brat, G. A., Murphy, S. N.
10.1101/2020.10.13.20201855 — Posted: 2020-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).